Variants of the BMP15 gene in a cohort of patients with premature ovarian failure

Human Reproduction

Volumn 25, Issue 6, 2010, Pages 1581-1587

  Tiotiu, D ^a   Alvaro Mercadal, B ^a   Imbert, R ^a,b   Verbist, J ^a   Demeestere, I ^a   De Leener, A ^a,b   Englert, Y ^a,b   Vassart, G ^a,b   Costagliola, S ^a   Delbaere, A ^a,b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

BMP15; Mutation; Polymorphism; Premature ovarian failure

Indexed keywords

BONE MORPHOGENETIC PROTEIN 15; DNA; HORMONE;

ADOLESCENT; ADULT; AFRICA; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DNA EXTRACTION; DNA SEQUENCE; EXON; FEMALE; GENE AMPLIFICATION; GENE INSERTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; INTRON; KARYOTYPE; MISSENSE MUTATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREDICTION; PREMATURE OVARIAN FAILURE; PROTEIN FUNCTION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

MAMMALIA;

EID: 77952852438     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deq073     Document Type: Article

References (29)

1. Aittomäki KL, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, Kaskikari R, Sankila EM, Lehväslaiho H, Engel AR et al. Mutation in the Follicle-Stimulating Hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995;82:959-967.
2. Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis 2006;6:1-9.
3. Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 2004; 75:106-111.
4. Di Pasquale E, Rossetti R, Marozzi A, Bodega B, Borgato S, Cavallo L, Einaudi S, Radetti G, Saco M, Wasniewska M et al. Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab 2006;91:1976-1979.
5. Dixit H, Rao LK, Padmalatha V, Kanakavalli M, Deenadayal M, Gupta N, Chakravarty B, Singh L. Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure. Menopause 2005;12:749-754.
6. Dixit H, Rao LK, Padmalatha VV, Kanakavalli M, Deenadayal M, Gupta N, Chakrabarty B, Singh L. Missense mutations in the BMP15 gene are associated with ovarian failure. Hum Genet 2006;119:408-415.
7. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 1996;383:531-535.
8. Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM. Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol 1999;13:1035-1048.
9. Galloway SM, McNatty KP, Cambridge LM, Laitinen MPE, Juengel JL, Jokiranta TS, McLaren RJ, Luiro K, Dodds KG, Montgomery GW et al. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 2000;25:279-283.
10. Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update 2005;11:391-410.
11. Hanrahan JP, Gregan SM, Mulsant P, Mullen M, Davis GH, Powell R, Galloway SM. Mutations in the genes for oocyte-derived growth factors GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and Belclare sheep (Ovis aries). Biol Reprod 2004;70:900-909.
12. Hashimoto O, Moore KR, Shimasaki S. Posttranslational processing of mouse and human BMP-15. Potential implication in the determination of ovulation quota. Proc Natl Acad Sci USA 2005;102:5426-5431.
13. Kovanci E, Rohozinski J, Simpson JL, Heard MJ, Bishop CE, Carson SA. Growth differentiating factor-9 mutations may be associated with premature ovarian failure. Fertil Steril 2007;87:143-146.
14. Laissue P, Christin-Maitre S, Touraine P, Kuttenn F, Ritvos O, Aittomaki K, Bourcignaux N, Jacquesson L, Bouchard P, Frydman R et al. Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol 2006;154:739-744.
15. Lakhal B, Laissue P, Braham R, Elghezal H, Saâd A, Fellous M, Veitia RA. A novel BMP15 variant, potentially affecting the signal peptide, in a familial case of premature ovarian failure. Clin Endocrinol 2009;71:752-753.
16. Lakhal B, Laissue P, Braham R, Elghezal H, Saâd A, Fellous M, Veitia RA. BMP15 and premature ovarian failure: causal mutations, variants, polymorphisms? Clin Endocrinol 2010;72:425-426.
17. Ledig S, Röpke A, Haeusler G, Hinney B, Wieacker P. BMP15 mutations in XX gonadal dysgenesis and premature ovarian failure. Am J Obstet Gynecol 2008;198:84e1-85
18. Liao WX, Moore RK, Shimasaki S. Functional and molecular characterization of naturally occurring mutations in the oocyte-secreted factors bone morphogenetic protein-15 and growth and differentiation factor-9. J Biol Chem 2004;279:17391-17396.
19. Moron FJ, Mendoza N, Quereda F, Vazquez F, Ramirez-Lorca R, Velasco J, Gallo JL, Salinas A, Martinez-Astorquiza T, Sanchez-Borrego R et al. Pyrosequencing technology for automated detection of the BMP15 A180T variant in Spanish postmenopausal women. Clin Chem 2007; 53:1162-1164.
20. Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 2003;31:3812-3814.
21. Otsuka F, Yao Z, Lee T, Yamamoto S, Erickson GF, Shimasaki S. Bone Morphogenetic Protein-15. Identification of target cells and biological functions. J Biol Chem 2000;275:39523-39528.
22. Rossetti R, Di Pasquale E, Marozzi A, Bione S, Toniolo D, Grammatico P, Nelson LM, Beck-Peccoz P, Persani L. BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive protein. Hum Mutat 2009;30:804-810.
23. Roy A, Matzuk MM. Deconstructing mammalian reproduction: using knockouts to define fertility pathways. Reproduction 2006;131:207-219.
24. Shimasaki S, Moore RK, Otsuka F, Erickson GF. The bone morphogenetic protein system in mammalian reproduction. Endocr Rev 2004; 25:72-101.
25. Sinha P, Kuruba N. Premature ovarian failure. J Obstet Gynaecol 2007; 27:16-19.
26. Sunyaev S, Ramensky V, Koch I, Lathe W III, Kondrashov AS, Bork P. Prediction of deleterious human alleles. Hum Mol Genet 2001;6: 591-597.
27. Wang B, Wen Q, Ni F, Zhou S, Wang J, Cao Y, Ma X. Analyses of growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) mutation in Chinese women with premature ovarian failure. Clin Endocrinol 2010;72:135-136.
28. Yan C, Wang P, DeMayo J, DeMayo FJ, Elvin JA, Carino C, Prasad SV, Skinner SS, Dunbar BS, Dube JL et al. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol 2001;15:854-866.
29. Zhao ZZ, Painter JN, Palmer JS, Webb PM, Hayward NK, Whiteman DC, Boomsma DI, Martin NG, Duffy DL, Montgomery GW. Variation in bone morphogenetic protein 15 is not associated with spontaneous human dizygotic twinning. Hum Reprod 2008;23:2372-2379.